Jupiter Wellness (NASDAQ:JUPW – Get Rating) is one of 28 publicly-traded companies in the “Toilet preparations” industry, but how does it compare to its competitors? We will compare Jupiter Wellness to similar businesses based on the strength of its earnings, dividends, institutional ownership, risk, valuation, profitability and analyst recommendations.
Profitability
This table compares Jupiter Wellness and its competitors’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Jupiter Wellness | -206.26% | -189.51% | -118.18% |
| Jupiter Wellness Competitors | -22.54% | 10.49% | -6.68% |
Institutional and Insider Ownership
14.1% of Jupiter Wellness shares are held by institutional investors. Comparatively, 41.8% of shares of all “Toilet preparations” companies are held by institutional investors. 32.9% of Jupiter Wellness shares are held by company insiders. Comparatively, 21.3% of shares of all “Toilet preparations” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Analyst Recommendations
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Jupiter Wellness | 0 | 0 | 0 | 0 | N/A |
| Jupiter Wellness Competitors | 132 | 1040 | 1163 | 26 | 2.46 |
As a group, “Toilet preparations” companies have a potential upside of 18.56%. Given Jupiter Wellness’ competitors higher probable upside, analysts plainly believe Jupiter Wellness has less favorable growth aspects than its competitors.
Earnings and Valuation
This table compares Jupiter Wellness and its competitors revenue, earnings per share and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Jupiter Wellness | $6.60 million | -$15.22 million | -0.59 |
| Jupiter Wellness Competitors | $5.76 billion | $295.98 million | 36.32 |
Jupiter Wellness’ competitors have higher revenue and earnings than Jupiter Wellness. Jupiter Wellness is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
Risk and Volatility
Jupiter Wellness has a beta of 0.22, suggesting that its stock price is 78% less volatile than the S&P 500. Comparatively, Jupiter Wellness’ competitors have a beta of 33.97, suggesting that their average stock price is 3,297% more volatile than the S&P 500.
Summary
Jupiter Wellness competitors beat Jupiter Wellness on 9 of the 10 factors compared.
About Jupiter Wellness
Jupiter Wellness, Inc. develops cannabidiol (CBD) based medical therapeutics and wellness products. The company's clinical pipeline includes CaniDermRX (JW-100), a novel topical formulation containing CBD and aspartame for the treatment of eczema, dermatitis, and actinic keratosis; JW-101, a prescription product for the treatment of burns; and JW-200, a non-prescription lotion/lip balm for the treatment of symptoms of cold sores. It also manufactures, distributes, and markets a line of consumer products, such as CBD-infused sunscreen under the CaniSun brand; CBD-infused skin care lotion under the CaniSkin brand; and products for the dermatological treatments of pain and inflammation under the CaniDermRX brand. The company was formerly known as CBD Brands, Inc. Jupiter Wellness, Inc. was incorporated in 2018 and is headquartered in Jupiter, Florida.
Receive News & Ratings for Jupiter Wellness Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jupiter Wellness and related companies with MarketBeat.com's FREE daily email newsletter.
